HPV 2010 Conference
Montreal Canada
July 3-8, 2010
Conclusion: Our data do not provide sufficient evidence to modify existing 3-dose schedules, but suggest that fewer than three doses may provide a high degree of protection against HPV-16/18 infection. Systematic evaluation of one- and two-dose schedules is justified.